2 12 18
28
32
a
    59
    • a 3b
  • Faculty
    • 1f
  • Avery D Posey
    • b
8
1a 2a

Faculty

61 16
19
1b
30

Avery D Posey, PhD

78 faculty photo 48
Assistant Professor of Pharmacology
7 8a
Department: Systems Pharmacology and Translational Therapeutics
4 1 23
1f Graduate Group Affiliations 8 a
b
1d
46 Contact information
 3c
PCAM SPE 8-106
3a 3400 Civic Center Blvd.
Philadelphia, PA 19104
26
35
9b
Email: aposey@pennmedicine.upenn.edu
12
4 3 3 3 2 4 b 1f
13 Education:
21 9 B.S. 35 (Bioinformatics and Computational Biology) c
57 University of Maryland, Baltimore County (UMBC), Baltimore, MD, 2005.
 21 9 B.S. 2f (Biochemistry and Molecular Biology) c
57 University of Maryland, Baltimore County (UMBC), Baltimore, MD, 2005.
 21 8 PhD 15 (Genetics) c
3f The University of Chicago, Chicago, IL, 2011.
 c
3 3 3 3 92 Permanent link
2 29
 
1d
25
21
b6 > Perelman School of Medicine   > Faculty   > Details a
1e 1d
2b 29
23

Selected Publications

134 Schwab RD, Hong SA, Bi X, Degaramo DA, Faruqi A, Brookens SK, Keane JT, Liu F, Musunuru K, Rader DJ, Posey AD Jr.: OxLDL-targeted Chimeric Antigen Receptor T Regulatory Cells Reduce Atherosclerotic Plaque Development. bioRxiv Jan 2025.

 c7 Posey AD Jr, Young RM, June CH.: Future perspectives on engineered T cells for cancer. Trends Cancer 10(8): 687-695, Aug 2024.

 2d3 Patel RP, Ghilardi G, Zhang Y, Chiang YH, Xie W, Guruprasad P, Kim KH, Chun I, Angelos MG, Pajarillo R, Hong SJ, Lee YG, Shestova O, Shaw C, Cohen I, Gupta A, Vu T, Qian D, Yang S, Nimmagadda A, Snook AE, Siciliano N, Rotolo A, Inamdar A, Harris J, Ugwuanyi O, Wang M, Carturan A, Paruzzo L, Chen L, Ballard HJ, Blanchard T, Xu C, Abdel-Mohsen M, Gabunia K, Wysocka M, Linette GP, Carreno B, Barrett DM, Teachey DT, Posey AD, Powell DJ Jr, Sauter CT, Pileri S, Pillai V, Scholler J, Rook AH, Schuster SJ, Barta SK, Porazzi P, Ruella M.: CD5 deletion enhances the antitumor activity of adoptive T cell therapies. Sci Immunol 9(97): eadn6509, Jul 2024.

 162 Emens LA, Romero PJ, Anderson AC, Bruno TC, Capitini CM, Collyar D, Gulley JL, Hwu P, Posey AD Jr, Silk AW, Wargo JA.: Challenges and opportunities in cancer immunotherapy: a Society for Immunotherapy of Cancer (SITC) strategic vision. J Immunother Cancer 12(6): e009063, Jun 2024.

 e9 Sosnoski HM, Posey AD Jr.: Therapeutic intersections: Expanding benefits of CD19 CAR T cells from cancer to autoimmunity. Cell Stem Cell 31: 437-438, Apr 2024.

 c6 Dagher OK, Posey AD Jr.: Forks in the road for CAR T and CAR NK cell cancer therapies. Nat Immunol Page: 1994-2007, Dec 2023.

 167 Aasted MKM, Groen AC, Keane JT, Dabelsteen S, Tan E, Schnabel J, Liu F, Lewis HS, Theodoropulos C, Posey AD, Wandall HH.: Targeting Solid Cancers with a Cancer-Specific Monoclonal Antibody to Surface Expressed Aberrantly O-glycosylated Proteins. Mol Cancer Ther 22: 1204-1214, Oct 2023.

 157 Watanabe K, Gomez AM, Kuramitsu S, Siurala M, Da T, Agarwal S, Song D, Scholler J, Rotolo A, Posey AD, Rook AH, Haun PL, Ruella M, Young RM, June CH.: Identifying highly active anti-CCR4 CAR T cells for the treatment of T-cell lymphoma. Blood Adv 7: 3416-3430, Jul 2023.

 bc Dagher OK, Schwab RD, Brookens SK, Posey AD Jr.: Advances in cancer immunotherapies. Cell 186: 1814-1814, Apr 2023.

 105 Brookens SK, Posey AD Jr.: Chimeric Antigen Receptor T-Cell Therapy: Current Perspective on T Cell-Intrinsic, T Cell-Extrinsic, and Therapeutic Limitations. Cancer J Page: 28-33, Jan 2023.

 2c
7 1d
2c back to top
26 Last updated: 05/07/2025
34 The Trustees of the University of Pennsylvania c
1f
27
24
 
1d
18
1 49 2 2 1a 32 34
19
12 12 1a 14